- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
UCSF Chancellor to Assume Helm at Gates Foundation
18 December 2013 1:45 pm
Susan Desmond-Hellmann, the chancellor of the University of California, San Francisco (UCSF), will be the next CEO of the Bill & Melinda Gates Foundation. The oncologist and former Genentech executive will take the reins of the huge philanthropy from retiring CEO Jeff Raikes on 1 May 2014, overseeing the foundation’s activities in global public health, poverty, and education.
Before assuming the post as UCSF chancellor in 2009, Desmond-Hellmann was president of product development at pre-Roche Genentech “during some of the biotech’s most fruitful years,” according to FierceBiotech, leading the introduction of the targeted cancer drugs Avastin and Herceptin. Desmond-Hellmann was one of the few oncologists on staff at Genentech, says The New York Times, and was in charge of all clinical trials.
“Sue’s background in public health policy, research and development, and higher education, make her an exceptional fit for this role,” said Bill Gates, co-chair of the foundation, in a statement.